<DOC>
	<DOCNO>NCT02252536</DOCNO>
	<brief_summary>The purpose study determine whether gabapentin enacarbil effective treatment problem alcohol .</brief_summary>
	<brief_title>HORIZANT ( Gabapentin Enacarbil Extended-Release Tablets ) Treatment Alcohol Use Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Subjects must meet one follow inclusion criterion order eligible participation study : 1 . Be least 21 year age . 2 . Have current ( past 12 month ) DSM5 diagnosis AUD . 3 . Have BAC breathalyzer equal 0.000 s/he sign informed consent document ( either prior immediately sign consent ) . 4 . Be seek treatment problem alcohol . Additional evaluate clinic . Evaluations conduct clinic .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>alcohol use disorder</keyword>
	<keyword>alcoholism</keyword>
	<keyword>alcohol dependence</keyword>
	<keyword>drinking alcohol</keyword>
</DOC>